Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott puts the A in AMO

This article was originally published in The Tan Sheet

Executive Summary

The Abbott Park, Ill.-based health care company completes its acquisition of Advanced Medical Optics - now Abbott Medical Optics - which is No. 3 in the contact lens care market, Abbott says Feb. 26. The European Commission gave the merger final clearance Feb. 20, Abbott says. Santa Ana, Calif.-based AMO reported net sales of $285.2 million, a drop of 6.4 percent, in its final independent fiscal quarter (1"The Tan Sheet" Feb. 23, 2009, In Brief). ... Similac in Singapore: Abbott opens its $300 million nutritional manufacturing facility, its single largest investment in Asia to date. Abbott says Feb. 26 it built the facility in response to increased demand for Similac and other pediatric nutritionals. The facility can serve up to 1 million Asian children annually (2"The Tan Sheet" April 24, 2006, p. 10). Abbott also plans to base a nutrition science research and development center in Singapore, the firm says

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102648

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel